T

    Tela Bio Inc (TELA)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.70
    +0.05 (+7.69%)

    Market Cap: $31.43M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    28%(8/29)
    Avg Surprise
    -11.86%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.15
    Range$-0.19 - $-0.13
    5 analysts
    EPS Revisions
    1
    0
    7d
    1
    1
    30d
    EPS Estimate Drift
    90d ago$-0.16-7.9%
    60d ago$-0.15+1.3%
    30d ago$-0.15+1.3%
    7d ago$-0.15+1.3%
    Current$-0.15
    Revenue Consensus
    $21M
    Range$19M - $23M
    5 analysts
    Dec 31, 2026
    EPS Consensus$-0.18
    Range$-0.25 - $-0.12
    5 analysts
    Revenue Consensus
    $19M
    Range$17M - $20M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.18---
    Sep 26EST
    		-$-0.15---
    Jun 26
    		$-0.20$-0.17-17.65%Miss+9.1%
    Mar 26
    		$-0.21$-0.15-39.86%Miss+14.2%
    Dec 25
    		$-0.17$-0.18+5.56%Beat+26.1%
    Sep 25
    		$-0.19$-0.20+5.00%Beat+54.8%
    Jun 25
    		$-0.22$-0.18-22.22%Miss+56.9%
    Mar 25
    		$-0.25$-0.21-19.05%Miss+53.7%
    Dec 24
    		$-0.23$-0.22-3.60%Miss+56.6%
    Sep 24
    		$-0.42$-0.42+0.00%Beat+6.7%
    Jun 24
    		$-0.51$-0.47-8.51%Miss-10.9%
    Mar 24
    		$-0.54$-0.51-5.88%Miss+14.3%
    Dec 23
    		$-0.53$-0.43-23.26%Miss-1.9%
    Sep 23
    		$-0.45$-0.27-66.67%Miss+29.7%
    Jun 23
    		$-0.46$-0.52+11.54%Beat+41.8%
    Mar 23
    		$-0.63$-0.56-12.50%Miss+16.0%
    Dec 22
    		$-0.52$-0.54+3.70%Beat+11.9%
    Sep 22
    		$-0.64$-0.56-14.29%Miss-12.3%
    Jun 22
    		$-0.79$-0.62-27.42%Miss-38.6%
    Mar 22
    		$-0.75$-0.56-33.93%Miss-33.9%
    Dec 21
    		$-0.59$-0.55-7.27%Miss-9.3%
    Sep 21
    		$-0.57$-0.52-9.62%Miss-7.5%
    Jun 21
    		$-0.57$-0.52-9.62%Miss-7.5%
    Mar 21
    		$-0.56$-0.48-16.67%Miss+11.1%
    Dec 20
    		$-0.54$-0.49-10.20%Miss+5.3%
    Sep 20
    		$-0.53$-0.48-10.42%Miss+10.2%
    Jun 20
    		$-0.53$-0.59+10.17%Beat-12.8%
    Mar 20
    		$-0.63$-0.56-12.50%Miss-
    Dec 19
    		$-0.57$-0.59+3.39%Beat-
    Sep 19
    		$-0.59$-0.45-31.11%Miss-
    Jun 19
    		$-0.47$-0.58+18.97%Beat-

    Key Metrics

    Valuation
    P/E Ratio-0.90EV/EBITDA-5.01x
    Price/FCF-1.27xFCF Yield-78.68%
    Profitability
    Profit Margin-51.50%Operating Margin-48.10%
    ROE-617.00%ROIC-82.21%
    Financial Health
    Debt/Equity-3.53xInterest Coverage-4.21x
    Current Ratio2.99xQuick Ratio2.38x
    Trading Statistics
    Beta1.36Avg Volume267.03K
    52-Week High$1.8752-Week Low$0.50

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.66
    SMA 20$0.73
    SMA 50$0.74
    SMA 200$0.87
    EMA 10$0.68
    EMA 20$0.70
    EMA 50$0.75
    EMA 200$0.94

    MACD

    Line: -0.03Signal: -0.03Hist: -0.00

    ADX

    ADX: 16.3+DI: 22.2-DI: 16.3

    Aroon & PSAR

    Aroon Up44.0
    Aroon Down72.0
    PSAR$0.76

    Bollinger Bands

    Upper Band$0.94
    Lower Band$0.53
    %B Position5691%(Upper)
    Band Width0.42

    RSI (14-Day)

    Neutral
    48.2

    Momentum Oscillators

    Stoch %K22.2
    Stoch %D20.5
    Williams %R-67.5
    ROC (10d)8.6%
    Momentum0.06
    CCI (20d)-42.1
    MFI (14d)20.3

    Volatility Measures

    ATR (14d)$0.08(10.9%)
    StdDev (20d)0.10
    Hist Vol121.4%(High)

    Volume Flow

    VWAP$0.68
    OBV-9.4M
    AD Line-6.6M
    CMF (20d)0.291

    Volume Metrics

    Avg Vol (20d)290.0K
    Vol Ratio0.4x(Low)
    VWMA (20d)$0.73

    Pivot Points

    R3$0.75
    R2$0.72
    R1$0.69
    Pivot Point$0.66
    S1$0.63
    S2$0.60
    S3$0.56

    Advanced Oscillators

    TSI-11.26
    Ultimate Osc50.2
    KST-99.21

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$19.29M$19.06M$20.87M$20.69M$20.20M$18.52M$17.65M$18.96M$16.09M$16.60M$17.00M$15.05M
    Cost of Revenue$5.25M$6.44M$6.73M$6.72M$6.00M$5.91M$6.43M$6.10M$5.02M$5.27M$4.99M$4.66M
    Gross Profit$13.94M$12.52M$13.76M$13.97M$14.11M$12.51M$11.22M$12.86M$11.07M$11.34M$11.62M$10.39M
    Operating Expenses$23.23M$23.05M$20.40M$21.52M$23.19M$22.98M$19.57M$22.22M$22.64M$16.16M$23.90M$20.57M
    R&D$2.72M$2.34M$2.13M$2.35M$2.20M$2.54M$2.03M$2.07M$2.32M$2.39M$2.69M$2.37M
    SG&A$4.06M$4.17M$3.78M$3.95M$4.13M$3.84M$3.59M$3.68M$3.62M$3.83M$4.05M$3.73M
    Operating Income$-9,283,000$-10,526,000$-6,648,000$-7,554,000$-9,081,000$-10,472,000$-8,354,000$-9,365,000$-11,570,000$-4,826,000$-12,278,000$-10,181,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$2.08M$2.05M$2.52M$1.20M$1.19M$1.22M$1.28M$1.34M$1.33M$1.33M$1.34M$1.33M
    Income Before Tax$-11,202,000$-12,213,000$-8,896,000$-8,603,000$-9,890,000$-11,212,000$-9,352,000$-10,372,000$-12,600,000$-5,661,000$-12,890,000$-10,957,000
    Income Tax Expense$60,000$60,000$145,000$0$33,000$52,000$-144,000$0$0$0$0$0
    Net Income$-11,262,000$-12,273,000$-9,041,000$-8,603,000$-9,923,000$-11,264,000$-9,208,000$-10,372,000$-12,600,000$-5,661,000$-12,890,000$-10,957,000
    EBITDA$-8,860,000$-9,896,000$-6,146,000$-7,154,000$-8,432,000$-9,726,000$-7,803,000$-8,765,000$-11,020,000$-4,095,000$-11,384,000$-9,405,000
    EBIT$-9,126,000$-10,160,000$-6,371,000$-7,402,000$-8,702,000$-9,993,000$-8,069,000$-9,028,000$-11,269,000$-4,329,000$-11,545,000$-9,623,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TELA

    Government Contracts

    Gov Obligations (TTM)
    $11025
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    1
    New Awards (TTM)
    1
    Avg Remaining Term
    N/A

    Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C26126P0059Department of Veterans AffairsDepartment of Veterans Affairs$11025Nov 3, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    TELA Bio (TELA) CEO adds 12,500 shares in August buy

    TELA Bio, Inc.'s CEO, Heather C. Getz, purchased 12,500 shares of common stock on August 17, 2026, at a weighted average price of $0.6649 per share. This transaction increased her direct holdings to 532,500 shares. The purchase was made in an open market or private transaction and was not affirmed under a Rule 10b5-1 trading plan.

    Stock Titan•8/19/26•
    Bullish

    TELA Bio (TELA) CEO buys 15,000 shares at $0.6978

    TELA Bio, Inc.'s CEO, Heather C. Getz, purchased 15,000 shares of common stock on August 14, 2026, at a weighted average price of $0.6978 per share. This transaction increased her direct holdings to 520,000 shares. The purchase was an open-market or private transaction, and not made under a Rule 10b5-1 trading plan.

    Stock Titan•8/17/26•
    Bullish

    TELA Bio (TELA) stake: Nantahala group reports 12.94% ownership of 5.79M shares

    Nantahala Capital Management, LLC, along with Wilmot B. Harkey and Daniel Mack, has reported an amended beneficial ownership of 12.94% of TELA Bio, Inc. common stock, totaling 5,794,114 shares as of June 30, 2026. This stake is held by funds and managed accounts advised by Nantahala, with all reporting persons sharing voting and dispositive power over these shares. Blackwell Partners LLC – Series A, a fund advised by Nantahala, holds economic rights to dividends and sale proceeds on more than five percent of the outstanding common stock.

    Stock Titan•8/14/26•
    Neutral

    TELA BIO (TELA): SilverArc Capital and Devesh Gandhi disclose 2.14M-share 4.8% stake

    SilverArc Capital Management, LLC and Devesh Gandhi have filed an amended Schedule 13G, disclosing a beneficial ownership of 2,137,201 shares of TELA Bio, Inc. Class A Common Stock, representing 4.8% of the class. The filing indicates they hold shared voting and dispositive power over all these shares, with no sole power, and explicitly state their ownership is 5 percent or less of the outstanding Class A Common Stock. This passive investment disclosure provides transparency into their stake in TELA BIO.

    Stock Titan•8/14/26•
    Neutral

    Analysts Have Been Trimming Their TELA Bio, Inc. (NASDAQ:TELA) Price Target After Its Latest Report

    TELA Bio, Inc. missed its latest quarterly earnings expectations, reporting lower-than-anticipated revenues of US$19m and a larger loss per share of US$0.20. Following these results, analysts have reduced their 2026 revenue forecasts to US$82.4m and increased their loss per share estimates to US$0.77, leading to a 6.7% cut in the consensus price target to US$2.10. The company's projected revenue growth rate has also slowed significantly compared to its historical performance, aligning with the broader industry's growth forecast.

    Simply Wall Street•8/13/26•
    Bearish

    Frequently Asked Questions About TELA

    Does TELA pay dividends?
    Tela Bio Inc (TELA) does not currently pay a regular dividend.
    What is TELA's market cap?
    Tela Bio Inc (TELA) has a market capitalization of $31.43M with a current stock price of $0.70.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In